These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37086280)

  • 21. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.
    Liang Z; Pan L; Shi J; Zhang L
    Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma.
    Yue Z; Wang D; Li X
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and immune-related value of STK17B in skin cutaneous melanoma.
    Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J
    PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma.
    Cen X; Li M; Yao A; Zheng Y; Lai W
    J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
    Wu Z; Zhang R; Bao J; Yin M; Wang X
    Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and immune infiltration implications of SIGLEC9 in SKCM.
    Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R
    Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.
    Chen J; Yu N; Ou S; Wang X; Li H; Zhu H
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11619-11634. PubMed ID: 37401939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
    Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
    Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of skin cutaneous melanoma prognosis model based on vascular mimicry risk score.
    Wang Y; Zou L; Song M; Zong J; Wang S; Meng L; Jia Z; Zhao L; Han X; Lu M
    Medicine (Baltimore); 2024 Feb; 103(7):e36679. PubMed ID: 38363903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of Prognostic Risk Model of Patients with Skin Cutaneous Melanoma Based on TCGA-SKCM Methylation Cohort.
    Yu X; Cong P; Wei W; Zhou Y; Bao Z; Hou H
    Comput Math Methods Med; 2022; 2022():4261329. PubMed ID: 36060650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
    Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
    Front Immunol; 2022; 13():914108. PubMed ID: 36032150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CD8
    Sun S; Zhi Z; Su Y; Sun J; Li Q
    Front Immunol; 2022; 13():1039565. PubMed ID: 36341357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma.
    Sun Y; Lei S; Luo X; Jiang C; Li Z
    Front Pharmacol; 2023; 14():1129544. PubMed ID: 37138850
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophil extracellular trap related risk score exhibits crucial prognostic value in skin cutaneous melanoma, associating with distinct immune characteristics.
    Zhang H; Bi X; Yan P; Wang C
    Skin Res Technol; 2024 Aug; 30(8):e70008. PubMed ID: 39167030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma.
    Song B; Chi H; Peng G; Song Y; Cui Z; Zhu Y; Chen G; Wu J; Liu W; Dong C; Wang Y; Xu K; Yu Z; Song B
    Front Oncol; 2022; 12():975255. PubMed ID: 36059641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.